| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 347,372 | 627,324 | 897,788 | 694,332 | | Cost of Revenue | 279,359 | 510,626 | 753,486 | 585,306 | | | Gross Profit | 68,013 | 116,698 | 144,302 | 109,026 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 53,632 | 59,188 | 71,933 | 65,760 | | Non Recurring | (2,521) | (939) | (2,008) | (2,155) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 16,902 | 58,449 | 74,377 | 45,421 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,846 | 9,515 | 5,988 | 3,777 | | Earnings Before Interest And Taxes | 22,304 | 68,342 | 79,108 | 49,726 | | Interest Expense | 3,488 | 3,130 | 5,303 | 3,058 | | Income Before Tax | 18,816 | 65,212 | 73,805 | 46,668 | | Income Tax Expense | 4,829 | 21,011 | 21,473 | 13,081 | | Minority Interest |
-
| (12,276) | (594) | (7,969) | | | | Net Income From Continuing Ops | 13,987 | 31,925 | 51,738 | 25,618 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,987 | 31,925 | 51,738 | 25,618 | | Preferred Stock And Other Adjustments | (5,067) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,920 | $31,925 | $51,738 | $25,618 |
|
0.33% Nasdaq 
Income Statement
